Trade LNSR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
LENSAR, Inc. (LNSR) is trading at US$8.37, down 1.12% today as of Aug 28, 10:21 EDT. The company has a market capitalisation of US$106.64M. Over the past 52 weeks, LNSR has traded between US$4.95 and US$12.94. On Syfe you can trade LNSR with $0 commission and add it to your watchlist.
| Previous close | US$8.46 |
|---|---|
| Market cap | US$106.64M |
| P/E ratio | 130.26 |
| 52-week range | US$4.95 – US$12.94 |
| Volume | 97.41K |
| Exchange | US |
Add to Watchlist
Set Price Alert
LENSAR, Inc.
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Year: 2020
BTIG Upgrades LENSAR to Buy From Neutral, Price Target is $10
Mar 18, 11:12 AM · MT Newswires
Sector Update: Health Care Stocks Fall Late Afternoon
Mar 17, 7:51 PM · MT Newswires
Sector Update: Health Care Stocks Decline Tuesday Afternoon
Mar 17, 6:24 PM · MT Newswires
Top Midday Decliners
Mar 17, 5:58 PM · MT Newswires
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Mar 17, 1:16 PM · MT Newswires
LENSAR, Inc. (LNSR) stock is trading at US$8.37, -1.12% from the previous close of US$8.46.
The market cap for LENSAR, Inc. (LNSR) stock is approximately US$106.64M.
The price-to-earnings ratio for LENSAR, Inc. (LNSR) is 130.26, based on the latest reported earnings.
The 52-week high for LENSAR, Inc. (LNSR) stock is US$12.94.
The 52-week low for LENSAR, Inc. (LNSR) stock is US$4.95.
LENSAR, Inc. (LNSR) does not currently pay a dividend.
Stay on top of LNSR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
